ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,099.96
      1.02%
      US Tech 100
      17,244.80
      1.57%
      Dow Jones
      38,239.66
      0.40%
      Brent Oil
      88.165
      0.00%
      Bitcoin
      63,667.57
      0.40%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. BioPharmX Corporation (BPMX)

      7. BioPharmX Corporation (BPMX) News

      BPMX

      BioPharmX (BPMX)

      BioPharmX Corporation
      		Date:
      Sort by:
       Showing the most relevant articles for your search:AMEX:BPMX
      DateTimeSourceHeadlineSymbolCompany
      05/29/20206:04AMEdgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:BPMXBioPharmX Corporation
      05/28/20205:01PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:BPMXBioPharmX Corporation
      05/27/20205:23PMEdgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:BPMXBioPharmX Corporation
      05/22/20205:17PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
      05/19/20204:41PMGlobeNewswire Inc.Timber Pharmaceuticals Announces Investor Conference CallAMEX:BPMXBioPharmX Corporation
      05/15/20204:36PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
      05/15/20204:05PMPR Newswire (US)BioPharmX Announces 1-for-12 Reverse Stock Split Merger Transaction Expected to Close on May 18, 2020AMEX:BPMXBioPharmX Corporation
      05/13/20204:33PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
      05/13/20204:31PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:BPMXBioPharmX Corporation
      05/13/20204:05PMPR Newswire (US)BioPharmX Corporation Announces Approval of Merger by Stockholders at Special MeetingAMEX:BPMXBioPharmX Corporation
      05/11/20204:09PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:BPMXBioPharmX Corporation
      05/11/20204:09PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
      05/08/20209:00AMPR Newswire (US)BioPharmX Corporation Urges Stockholders to Vote Now on Proposed Merger with Timber PharmaceuticalsAMEX:BPMXBioPharmX Corporation
      05/07/20206:05AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:BPMXBioPharmX Corporation
      04/27/20204:20PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:BPMXBioPharmX Corporation
      04/27/20204:13PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
      04/27/20204:12PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:BPMXBioPharmX Corporation
      04/27/20204:05PMPR Newswire (US)BioPharmX Corporation Announces that its Special Stockholders' Meeting will now be held on Wednesday, May 13, 2020 at 10:00 A...AMEX:BPMXBioPharmX Corporation
      04/06/20204:55PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
      04/06/20204:53PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:BPMXBioPharmX Corporation
      04/06/20204:30PMPR Newswire (US)Timber Pharmaceuticals Announces Award of Second Tranche of FDA Orphan Products Clinical Trials GrantAMEX:BPMXBioPharmX Corporation
      04/01/20204:18PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:BPMXBioPharmX Corporation
      04/01/20206:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)AMEX:BPMXBioPharmX Corporation
      03/30/20204:04PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
      03/30/20204:02PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:BPMXBioPharmX Corporation
      03/30/20206:17AMEdgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)AMEX:BPMXBioPharmX Corporation
      03/25/20204:15PMPR Newswire (US)BioPharmX Receives Notice of Delisting from NYSE American But Stock will Remain TradingAMEX:BPMXBioPharmX Corporation
      03/23/20204:24PMEdgar (US Regulatory)Annual Report (10-k)AMEX:BPMXBioPharmX Corporation
      02/20/20206:03AMEdgar (US Regulatory)Securities Registration: Business Combination (s-4)AMEX:BPMXBioPharmX Corporation
      02/18/20204:04PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
       Showing the most relevant articles for your search:AMEX:BPMX